Confluence Acquires Risk Analytics Provider Orfival

Vendor will gain footprint in Europe from deal.

brussels-web
Orfival, based in Belgium, gives Confluence a gateway to the European buy-side market.

The acquisition will allow Confluence clients access to Orfival's performance measurement and attribution analytics, and will boost the vendor's abilities in other areas, such as reporting and benchmark comparison.

"When looking to grow Confluence we aimed to find businesses which have products or services that complement our existing offerings to add greater value to the global asset management industry," says Mark Evans, CEO at Confluence. "Orfival is just that, as it brings extraordinary subject matter expertise and research capabilities as well as a deep understanding of the European market. The region is one which we have strategically targeted for business growth and this acquisition makes our European networks stronger while allowing us to market Orfival products to our existing North American network."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here